Download Pain and Addiction - AIDS Education and Training Centers

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Adherence (medicine) wikipedia , lookup

Bad Pharma wikipedia , lookup

Neuropharmacology wikipedia , lookup

Polysubstance dependence wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Transcript
PAIN AND ADDICTION
Steven Rapaport, MD
Attending Physician
Comprehensive HIV Center
Saint Vincent’s Catholic Medical Center
A Local Performance Site of the NY/NJ AIDS
Education and Training Center
New York City
Medical Director
West Midtown Medical Group
New York City
Case
Alex is a 44 year old man having difficulty with pain
medications
He has AIDS
CD4 nadir 75 several years ago
Currently on Kaletra and Combivir
Recent CD4 325 Viral Load <50
Also has hepatitis C infection with documented viremia
(type 1A) and mild elevation in AST and ALT
Pain problem: avascular necrosis of left hip for several
years, requiring opioid analgesics
Initially treated with percocet, up to 8 tablets daily
Switched to MS Contin due to concern over tylenol exposure
Eventually stabilized on MS Contin 30 mg twice daily and
hydromorphone (dilaudid) 2 mg to 4 mg every 4 hours for
break-though pain
S/P total hip replacement 6 months ago
After hospital discharge, he was given Rx for percocet by
orthopedist
He is currently taking 8 percocets daily
His primary provider has tried unsuccessfully to
discontinue the percocets
He no longer has hip pain, but he complains of
irritability, malaise, insomnia, generalized body pain,
abdominal cramping, diarrhea, sweats and chills
when he doesn’t take them
Both the patient and his primary provider are
concerned that he has developed an addiction to
pain medications
What is your assessment?
PHYSICAL DEPENDENCE
A state of adaptation characterized by a class
specific drug withdrawal syndrome that can be
produced by the abrupt cessation, rapid dose
reduction, decreasing blood level of the drug, or
administration of an antagonist
A predictable drug effect
Consensus statement of the American Pain Society, American
Academy of Pain Medicine, and the American Society of Addiction
Medicine (2001)
ADDICTION
A primary, chronic condition characterized by:
Impaired control over drug use, compulsive use
Craving, preoccupation with obtaining and using the drug
Continued use despite harm (physical, psychologic,
social)
Consensus statement of the American Pain Society, American
Academy of Pain Medicine, and the American Society of
Addiction Medicine (2001)
DSM-IV CRITERIA NOT WELL
SUITED FOR PAIN PATIENTS
SUBSTANCE DEPENDENCE DISORDER
(three or more)
Larger amounts used for longer time than intended
Persistent desire or unsuccessful attempts to control
use
Great deal of time spent in activities related to use
Important social, occupational, or recreational
activities given up or reduced due to substance use
Continued use despite problems caused or
exacerbated by use
Tolerance
Withdrawal (physical dependence)
KEY QUESTIONS:
What percentage of patients treated with opioids for
chronic pain will develop an addiction disorder?
Are there risk factors for the development of
addictions?
How can you tell if the patient is developing an
addiction disorder?
“MALIGNANT” VS. “NON-MALIGNANT”
Concerns about addiction are usually irrelevant in
palliative care at the end of life
Nonetheless, fear of addiction contributes to
unnecessary pain and suffering, even at the end of life.
Fear of regulatory scrutiny inhibits appropriate
prescribing by physicians, even at the end of life.
On the other hand, opioid analgesic therapy for chronic
non-malignant pain should involve a careful assessment
of benefits and risks, including addiction.
PAIN AND AIDS
Late stage AIDS is often associated with pain
Before the advent of HAART, AIDS was always a
terminal disease, similar to incurable cancer
Chronic pain in the HIV/AIDS in the post-HAART era is
more often similar to other non-malignant pain conditions
(chronic back pain, arthritis) and the use of opioid
analgesics should involve a careful risk-benefit analysis
PAIN AND ADDICTION
What percentage of patients treated with opioids
for chronic pain will develop addiction?
Pain specialist have reported that addiction is a
rare occurrence among chronic pain patients
Published rates of addiction in chronic pain
populations
 3% to 18%
PAIN AND ADDICTION
On the other hand…
Rates of addiction problems in the general US
population:
Alcoholism: 10%
Drug abuse: 5%
Many patients with opiate addiction (up to 25% in some
surveys), report that their addiction resulted from
prescribed opioid analgesics.
PAIN AND ADDICTION
In retrospective analyses, nearly all
chronic pain patients who developed
problems with opioid use had a prior
history of addiction.
However, prospective longitudinal studies,
in well-characterized patient populations,
are lacking
RISK FACTORS FOR ADDICTION
(not evidence-based)
Prior history of addiction
Family history of addiction
Co-occurring psychiatric disorders
Use of short-acting opioids which are more
“reinforcing” than long-acting opioids
CASE:
Used drugs extensively in the 1980’s and 1990’s,
especially cocaine, crystal methamphetamine, alcohol, and
Marijuana, while working in the fashion industry, where
drug use was very common.
He injected heroin several times in college, but
“didn’t really like it”
He lost several jobs due to inability to control his drug use.
Attended detox and rehab in 1996 after a suicide attempt.
He continues to drink alcohol on weekends, up to 4 to 5
drinks per night, despite having been told that he should
stop because of his hepatitis C infection. Denies other
drugs since leaving the rehab.
FAMILY HISTORY:
His father was an alcoholic, died of cirrhosis.
His brother was addicted to heroin, now in a
methadone program.
MENTAL HEALTH:
He has a history of depression in past, which was
associated with periods of drug use. He is not
currently depressed and is on effexor.
CASE
Alex is concerned that he is having difficulty
getting off the pain medications, but he:
Denies craving for the pain medications
Has a half-full bottle of percocet at home and
left-over MS Contin from an old prescription.
Never takes them for a euphoric effect or
for any other effects other than to eliminate
the withdrawal symptoms.
What is your assessment?
SIGNS OF ADDICTION IN PAIN
PATIENTS:
“ABERRANT BEHAVIORS”
Lost or stolen Rx
Escalating doses, early renewals
Obtaining medication form other sources
Use of pain medications for psychic effects,
e.g. to relieve anxiety, increase energy, or for
euphoria
Unwillingness to try non-opioid mediations
Deterioration in function
ADDICTION IN PAIN PATIENTS:
Impaired control, compulsive use
Craving, preoccupation
Continued use despite harm, which leads
to deterioration in function
PSEUDOADDICTION
Behaviors that resemble addiction that occur when pain is
under-treated.
“Watching the clock” for pain medications in hospital
“Drug seeking” and “doctor shopping”
Asking for specific medications by name
Hoarding of medications
Unsanctioned escalation in dose
These behaviors resolve when the pain is adequately
treated.
CASE:
In order to treat opioid withdrawal, Alex received a
long acting opioid which slowly tapered off over
the course of several weeks.
He completed the taper without any complications
and did not display any aberrant behaviors.
Despite being advised to abstain completely from
alcohol and cigarettes, he continues to drink and
smoke as before.
CASE: version #2
The surgery was unsuccessful and he
continues to have severe pain
How should his pain be managed?
PAIN AND ADDICTION
Chronic pain is very common among patients with
addictions disorders
trauma
medical illness
Chronic opioid use, e.g. methadone maintenance,
may lead to increased sensitivity to pain (hyperalgesia)
PAIN AND ADDICTION
Should you prescribe opioid analgesics for patients with
addiction disorders?
Regulatory issues (will you get in trouble with the DEA?)
Clinical issues (is it good medicine?)
PAIN AND ADDICTION
REGULATORY ISSUES
The use of opioids to treat opioid addiction is limited to
federally approved Opioid Treatment Programs
(Narcotic Drug Treatment Act of 1974) and is monitored
by the DEA and State authorities
Office-based treatment of opioid addiction with
buprenorphine is allowed under the Drug Addiction
Treatment Act of 2000
Physicians may prescribe opioids to addicts for pain, as
long as the chart clearly documents that the opioids are
being used to treat pain and not addiction
DIVERSION
The diversion of prescribed controlled substances
for other than legitimate medical uses poses a
threat to the individual and society.
Prescribers have a responsibility to minimize the
potential for the abuse and diversion of controlled
substances, but efforts to stop diversion should not
interfere with the legitimate use of opioids for pain
management.
from Model Policy on Controlled Substances for
Treatment of Pain: Federation of State Medical Boards
(2004)
PATIENT EVALUATION
Complete history and physical
Detailed pain history, physical exam, prior treatment
history, indications for opioid analgesic (under accepted
medical standard of care)
History of substance abuse
Psychiatric history
Communicate with prior clinicians, obtain prior records
INFORMED CONSENT
Discussion of risks and benefits
Consider use of a written agreement
INFORMED CONSENT
WRITTEN AGREEMENT
One prescriber
One pharmacy
Patient agrees to safeguard medication
No replacement of lost or stolen medication
No illegal substances
No diversion (selling, sharing)
Urine toxicology testing
PERIODIC REVIEW
Analgesic response
Aberrant behaviors, signs of addiction or
diversion
Functional status: patients on effective analgesia
should have improved function; patients with
addiction disorders will get worse
Do the benefits of opioid analgesics continue to
outweigh any risks?
Documentation
Chart everything!